首页> 外文学位 >A chemical biology approach to discover the biological targets of the antiepileptic drug lacosamide.
【24h】

A chemical biology approach to discover the biological targets of the antiepileptic drug lacosamide.

机译:一种化学生物学方法,用于发现抗癫痫药lacosamide的生物学目标。

获取原文
获取原文并翻译 | 示例

摘要

Lacosamide (VimpatRTM) is a potent antiepileptic drug that received market approval for the adjunctive treatment of partial-onset seizures in adults in Europe and the United States. The pharmacological studies document that lacosamide has a unique profile of activity that differentiates it from existing antiepileptic agents. Based on these findings, we hypothesized that lacosamide binds to different proteins, with low-to-modest affinity. This research project aims to identify the lacosamide biological targets that modulate function and toxicity. We propose a novel target identification approach where an affinity bait (AB) and a chemical reporter (CR) group are strategically placed within the lacosamide framework. These compounds are termed lacosamide AB&CR agents. The AB moiety leads to permanent capture of the binding protein while the bioorthogonal CR unit is used for either detection or isolation of the complex upon reaction with a probe. The understanding of lacosamide's mechanism(s) of action will help increase our understanding of epileptic disorders, and permit the rational development of new clinical agents.;In the first part of our study, we explored the structure-activity relationship (SAR) for the 3-oxy site in lacosamide. We showed that incorporation of non-bulky, hydrophobic groups at this site provided lacosamide derivatives with excellent activities in animal seizure models. This information was used to design and stereospecifically synthesize a series of lacosamide AB&CR agents where either the AB or the CR group was installed at the 3-oxy site. Most lacosamide AB&CR agents were evaluated for anticonvulsant activity in animal models.;In the second part of our study, the lacosamide AB&CR agents were utilized to interrogate the rat brain soluble and membrane-bound proteome for potential binding partners of lacosamide. We used several subcellular fractionation methods to deconvolute the rat brain proteome. Within each subcellular fraction, different protein purification methods were employed to partition the lysate and aid the identification process. Several potential proteins were selectively targeted by the lacosamide AB&CR agents. Further analysis did not confirm that these proteins were directly linked to lacosamide function. These studies documented the strengths and limitations of the AB&CR strategy for receptor identification and are discussed.
机译:Lacosamide(VimpatRTM)是一种有效的抗癫痫药,在欧洲和美国,已被批准用于成人部分发作的辅助治疗。药理研究表明,拉考酰胺具有独特的活性,可将其与现有的抗癫痫药区分开来。基于这些发现,我们假设拉考酰胺以低至中等的亲和力与不同蛋白质结合。该研究项目旨在鉴定调节功能和毒性的拉考酰胺生物靶标。我们提出了一种新型的目标识别方法,其中亲和力诱饵(AB)和化学报告者(CR)组被策略性地置于了拉可酰胺框架内。这些化合物称为拉考酰胺AB&CR剂。 AB部分可导致结合蛋白的永久捕获,而生物正交CR单元可在与探针反应后用于检测或分离复合物。对拉考沙酰胺作用机制的理解将有助于增进我们对癫痫病的理解,并允许合理开发新的临床药物。在研究的第一部分中,我们探索了药物的构效关系(SAR)。拉可酰胺中的3-氧基位。我们表明,在该位点掺入非疏松的疏水基团可提供在动物癫痫发作模型中具有出色活性的拉考酰胺衍生物。此信息用于设计和立体合成一系列拉考酰胺AB&CR试剂,其中AB或CR基团安装在3-氧基位点。在动物模型中评估了大多数拉考酰胺AB&CR剂的抗惊厥活性。在我们的研究的第二部分中,拉考酰胺AB&CR剂被用于研究大鼠脑可溶性和膜结合的蛋白质组,作为拉考酰胺的潜在结合伴侣。我们使用了几种亚细胞分级分离方法对大鼠脑蛋白质组进行去卷积。在每个亚细胞级分中,采用不同的蛋白质纯化方法来分配裂解物并帮助鉴定过程。 Lacosamide AB&CR剂选择性靶向了几种潜在的蛋白质。进一步的分析未证实这些蛋白质与拉考酰胺功能直接相关。这些研究记录了AB&CR受体识别策略的优势和局限性,并进行了讨论。

著录项

  • 作者

    Morieux, Pierre Philippe.;

  • 作者单位

    The University of North Carolina at Chapel Hill.;

  • 授予单位 The University of North Carolina at Chapel Hill.;
  • 学科 Biology Neuroscience.;Health Sciences Pharmacy.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 403 p.
  • 总页数 403
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号